Executive Director, National Primary Health Care Development Agency (NPHCDA), Dr Faisal Shuaib said 3.4 million doses of Oxford AstraZeneca COVID-19 vaccine have so far been utilised for the 1st and 2nd dose vaccinations.
This, he said, was approximately 88 per cent of the total COVID-19 vaccine stock in the country.
He gave the statistics while speaking at the national briefing of the COVID-19 Presidential Steering Committee on Monday, in Abuja.
He said 4,024,000 doses of Oxford/AstraZeneca vaccine were received by the Federal Government in March 2021.
According to him, 3.924 million came through the COVAX facility and another 100,000 doses from the Government of India.
“I am glad to inform you that 3.4 million doses have so far been utilised for the 1st and 2nd dose vaccinations, which is approximately 88 per cent of the total AstraZeneca COVID-19 vaccine stock in the country.
“As at today, the breakdown of the number of people vaccinated and the vaccine consumption is as follows:
“2,265,805 people vaccinated with the first dose; 1,175,341 people vaccinated with the second dose and this means 88 per cent vaccine doses have been used.
“Based on these data and comparative information from other countries, Nigeria continues to have the highest vaccination rates in Africa with approximately 87,000 people being vaccinated daily.
“Egypt, South Africa, Ghana and Senegal each have daily vaccination rates of 72,000, 52,600, 12,100 and 4,790 respectively.”
“It is pertinent to note that as of today, there is no vaccine with the expiration date of June 28, that has not been utilised, which means that there is currently zero balance of such vaccines in the country,” he said.